Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy
Open Access
- 15 February 2001
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 84 (4), 460-464
- https://doi.org/10.1054/bjoc.2000.1645
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.Journal of Clinical Oncology, 1998
- The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitroBritish Journal of Cancer, 1997
- Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastomaJournal of Neuro-Oncology, 1997
- A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatinEuropean Journal Of Cancer, 1995
- First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastomaEuropean Journal Of Cancer, 1995
- Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosisMedical and Pediatric Oncology, 1993
- Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.Journal of Clinical Oncology, 1992
- Enhanced Post-Irradiation Recovery of the Haemopoietic System In Animals Pretreated With A Variety of Cytotoxic AgentsCell Proliferation, 1978
- Sparing effect of cyclophosphamide (NSC-26271) pretreatment on animals lethally treated with gamma-irradiation.1976